{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:52:49Z","timestamp":1761540769720},"reference-count":20,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2007]]},"DOI":"10.2133\/dmpk.22.26","type":"journal-article","created":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T12:44:07Z","timestamp":1172753047000},"page":"26-32","source":"Crossref","is-referenced-by-count":16,"title":["Characteristics of Gastrointestinal Absorption of DX-9065a, a New Synthetic Anticoagulant"],"prefix":"10.2133","volume":"22","author":[{"given":"Yoshimine","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon L.","family":"Amidon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.22.26_bb0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2125.1989.tb05415.x","article-title":"Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations","volume":"28","author":"Dryjski","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.22.26_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1015368126304","article-title":"Argatroban","volume":"13","author":"Kathiresan","year":"2002","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.2133\/dmpk.22.26_bb0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0038-1642436","article-title":"DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa","volume":"71","author":"Hara","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.2133\/dmpk.22.26_bb0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0038-1649790","article-title":"DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats","volume":"74","author":"Hara","year":"1995","journal-title":"Thromb. Haemost."},{"key":"10.2133\/dmpk.22.26_bb0025","first-page":"1030","article-title":"DX-9065a, a novel synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies","volume":"276","author":"Herbert","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.22.26_bb0030","first-page":"53","article-title":"Deviations of intestinal drug absorption from the pH-partition theory","volume":"33","author":"Winne","year":"1987","journal-title":"Acta. Pharm. Technol."},{"key":"10.2133\/dmpk.22.26_bb0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1248\/bpb1978.7.452","article-title":"Intestinal absorption mechanism of amino-\u03b2-lactam antibiotics III: Kinetics of carrier-mediated transport across the rat small intestine in situ","volume":"7","author":"Nakashima","year":"1984","journal-title":"J. Pharm. Dyn."},{"key":"10.2133\/dmpk.22.26_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-5193(88)80123-1","article-title":"Determination of Intrinsic Membrane Transport Parameters from Perfused Intestine Experiments: A Boundary Layer Approach to Estimating the Aqueous and Unbiased Membrane Permeabilities","volume":"131","author":"Johnson","year":"1988","journal-title":"J. Theor. Biol."},{"key":"10.2133\/dmpk.22.26_bb0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/A:1015927004752","article-title":"Estimating human oral fraction dose absorbed: A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds","volume":"5","author":"Amidon","year":"1988","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.22.26_bb0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-5193(88)80124-3","article-title":"Membrane permeability parameters for some amino acids and \u03b2-lactam antibiotics: application of the boundary layer approach","volume":"131","author":"Hu","year":"1988","journal-title":"J. Theor. Biol."},{"key":"10.2133\/dmpk.22.26_bb0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1248\/bpb1978.14.363","article-title":"Effect of pH, dietary proteins and trypsin inhibitors on the hydrolytic rate of human granulocyte colony-stimulating factor (G-CSF) by rat digestive enzymes","volume":"14","author":"Takada","year":"1991","journal-title":"J. Pharmacobio-Dyn."},{"key":"10.2133\/dmpk.22.26_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0378-5173(86)90077-3","article-title":"Binding of antibiotics to rat intestinal mucin","volume":"30","author":"Niibuchi","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.2133\/dmpk.22.26_bb0065","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jps.2600740523","article-title":"Absorption potential: Estimating the fraction absorbed for orally administered compounds","volume":"74","author":"Dressman","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.22.26_bb0070","first-page":"301","article-title":"Oral absorption of peptides and proteins","volume":"2","author":"TenHoor","year":"1992","journal-title":"S.T.P. Pharm. Sci."},{"key":"10.2133\/dmpk.22.26_bb0075","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1248\/bpb.17.1256","article-title":"Intestinal absorption of Azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. I.: Possible factors for the low oral bioavailability in rats","volume":"17","author":"Sasaki","year":"1994","journal-title":"Biol. Pharm. Bull."},{"key":"10.2133\/dmpk.22.26_bb0080","first-page":"319","article-title":"The influence of experimental procedures and dose on the intestinal absorption of ammonium compound, benzomethamine","volume":"131","author":"Levine","year":"1961","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.2133\/dmpk.22.26_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jps.2600710120","article-title":"Theoretical and experimental studies of transport of micelle-solubilized solutes","volume":"71","author":"Amidon","year":"1982","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.22.26_bb0090","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1749-6632.1966.tb43008.x","article-title":"Effect of neomycin and kanamycin upon intestinal absorption","volume":"132","author":"Faloon","year":"1966","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.2133\/dmpk.22.26_bb0095","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1248\/cpb.34.3836","article-title":"Intestinal absorption of a \u03b2-adrenergic blocking agent, nadolol. II. Mechanism of the inhibitory effect on the intestinal absorption of nadolol by sodium cholate in rats","volume":"34","author":"Yamaguchi","year":"1986","journal-title":"Chem. Pharm. Bull."},{"key":"10.2133\/dmpk.22.26_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-5173(93)90250-J","article-title":"Reduced bioavailability of atenolol in man: the role of bile acids","volume":"89","author":"Barnwell","year":"1993","journal-title":"Int. J. Pharm."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715302299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715302299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T01:09:17Z","timestamp":1556154557000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715302299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"alternative-id":["S1347436715302299"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.22.26","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}